BioPharm Solutions Inc

Medtech · Private

Phase transition microneedle patch system for non-invasive protein and peptide drug delivery

Grants
$501K
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Phase-transition Hydrogel Microneedle$250,445
Federal grantDepartment of Health and Human Services · Phase I · Phase-transition Hydrogel Microneedle$250,445
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1930R3 Vascular Inc.—$75M
1931Medical Innovation Through Technology, Inc.——
1932KaRa MINDS——
1933BioPharm Solutions Inc——
1934ASC Queen Anne Galer LLC—$6.7M
1935QUINTERO & KONTOPOULOS PLLC——
1936INNOVATIVE DIAGNOSTICS, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.